Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Compound Heterozygosity Involving Other Dead ( DDX ) and Deah ( DHX ) Box Helicases Explains Seemingly Monoallelic Somatic and Germline DDX41 Mutations

Valeria Visconte, Carlos Bravo-Perez, Arda Durmaz, Luca Guarnera, Ishani Nautiyal, Megan Reynold, Nakisha D Williams, Yasuo Kubota, Naomi Kawashima, Benjamin Kroger, Stephen S. Chung, David S. Bosler, Carmelo Gurnari, Jaroslaw P. Maciejewski

Blood (2023) 142 (Supplement 1): 947.

https://doi.org/10.1182/blood-2023-187195

Published: 2023

Journal Articles

Incidence of Invasive Fungal Infections in CAR T-Cell Therapy Recipients: A Single-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 6921.

https://doi.org/10.1182/blood-2023-186596

Published: 2023

Journal Articles

Utilization and Barriers to Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma: A ‘Real-World’ Study of Treatment Patterns and Outcomes at a Safety-Net Versus a Tertiary Academic Hospital

Sharlene Dong, Heather Reves, Yu-Lun Liu, Radhika Kainthla, Aimaz Afrough, Julio Alvarenga, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Adeel Khan, Kiran Achut Kumar, Yazan F. Madanat, Heather R Wolfe, Elif Yilmaz, Farrukh T. Awan, Praveen Ramakrishnan Geethakumari

Blood (2023) 142 (Supplement 1): 2417.

https://doi.org/10.1182/blood-2023-188033

Published: 2023

Journal Articles

Somatic and Germline HLA Determinants of Immune Surveillance and Escape in Myelodysplastic Syndromes

Carmelo Gurnari, Arda Durmaz, Benjamin Kroger, Hussein Awada, Jacky Chen, Colin Hercus, Sébastien Hergalant, Carlos Bravo-Perez, Maria Teresa Voso, Jacob Scott, Valeria Visconte, Stephen S. Chung, Jaroslaw P. Maciejewski, Simona Pagliuca

Blood (2023) 142 (Supplement 1): 3220.

https://doi.org/10.1182/blood-2023-178890

Published: 2023

Journal Articles

Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm

Hsi-Hsien Hsieh, Huiyu Yao, Yue Ma, Yuannyu Zhang, Xue Xiao, Helen Stephens, Naureen Wajahat, Stephen S. Chung, Lin Xu, Jian Xu, Raajit K. Rampal, Lily Jun-shen Huang

Blood (2022) 140 (22): 2371–2384.

https://doi.org/10.1182/blood.2022016741

Published: 2022

Includes: Supplemental data

Journal Articles

Impact of First-Line Consolidative Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL): A 'Real-World' Study of Treatment Patterns and Outcomes at a Safety-Net Versus a Tertiary Academic Hospital

Heather Reves, Fatima Mahmood, Tanushree Prasad, Akshat M Patel, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Praveen Ramakrishnan

Blood (2022) 140 (Supplement 1): 13184–13185.

https://doi.org/10.1182/blood-2022-170764

Published: 2022

Journal Articles

Defining Clonal Hematopoiesis in Childhood Cancer Survivors[a Prospective, Single Center Study]

Chelsee Greer, Benjamin Kroger, Stephen S. Chung, Kathryn Dickerson

Blood (2022) 140 (Supplement 1): 8614–8615.

https://doi.org/10.1182/blood-2022-167625

Published: 2022

Journal Articles

Clonal Hematopoiesis and Heart Failure with Preserved Ejection Fraction

Toby Thomas, Yuanyuan Ji, Fatma Kalkan, Albert Son, Ambarish Pandey, Vinayak Subramanian, Naveen Premnath, Michalis Agathocleous, Qing Ding, Alexander G. Bick, Benjamin Kroger, Dan Tong, Stephen S. Chung

Blood (2022) 140 (Supplement 1): 8611–8612.

https://doi.org/10.1182/blood-2022-171138

Published: 2022

Journal Articles

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

Aishwarya Sannareddy, Heather Reves, Kefyalew Jaleta, Ramyakumari .Ramiahsankarasubramanian, Hetalkumari Patel, Madhusudhanan Narasimhan, Larry D. Anderson, Jr., Aimaz Afrough, Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Alagarraju Muthukumar, Praveen Ramakrishnan Geethakumari

Blood (2022) 140 (Supplement 1): 5203–5205.

https://doi.org/10.1182/blood-2022-171001

Published: 2022

Journal Articles

Treatment Patterns and Outcomes of Peripheral T-Cell Lymphoma (PTCL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution: Does Consolidative Autologous Stem Cell Transplantation (ASCT) Make a Difference?

Meredith Jackson, Heather Reves, Tanushree Prasad, Akshat M Patel, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Praveen Ramakrishnan Geethakumari

Blood (2022) 140 (Supplement 1): 5188–5189.

https://doi.org/10.1182/blood-2022-170517

Published: 2022

Journal Articles

Multi-Omic Approaches Reveal Leukemia Stem Cell Gene Regulatory Mechanisms

Sohini Chakraborty, Hidenori Kasahara, Iryna Berezniuk, Stephen S. Chung, Christopher Y. Park

Blood (2022) 140 (Supplement 1): 5874–5875.

https://doi.org/10.1182/blood-2022-170793

Published: 2022

Journal Articles

Impact of Bridging Therapy on Infectious Complications Post CAR T-Cell Therapy: The UT Southwestern Experience

Akshat M Patel, Brian Lue, Heather Reves, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Jeffrey M. Tessier, Praveen Ramakrishnan Geethakumari

Blood (2022) 140 (Supplement 1): 12793–12795.

https://doi.org/10.1182/blood-2022-158778

Published: 2022

Journal Articles

Evaluating Stem Cells to Predict Post-Transplant Relapse in the Myelodysplastic Syndromes

Benjamin Kroger, Yi Huang, Prapti Patel, Aimaz Afrough, Gurbakhash Kaur, Larry D. Anderson, Jr., Farrukh T. Awan, Praveen Ramakrishnan, Kunal Verma, Russell Vittrup, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat, Roni Tamari, Stephen S. Chung

Blood (2022) 140 (Supplement 1): 9833–9835.

https://doi.org/10.1182/blood-2022-171179

Published: 2022

Journal Articles

Prevalence of Clonal Hematopoiesis in Patients with Monoclonal Gammopathy of Undetermined Significance

Vianey Quaney, Benjamin Kroger, Aishwarya Sannareddy, Umar Khan, Fatma Kalkan, Robert H. Collins, Yazan F. Madanat, Madhuri Vusirikala, Yi Huang, Farrukh T. Awan, Praveen Ramakrishnan, Aimaz Afrough, Larry D. Anderson, Jr., Stephen S. Chung, Gurbakhash Kaur

Blood (2022) 140 (Supplement 1): 11418–11419.

https://doi.org/10.1182/blood-2022-171212

Published: 2022

Journal Articles

Post-Transplant Cyclophosphamide Associated with Increased Early Mixed Donor Chimerism in Myeloid Malignancies; A Single-Center Experience

Fieke W. Hoff, Prapti A. Patel, Stephen S. Chung, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Jaime Shahan, Courtney Dryden, Hetalkumari Patel, Afrough Aimaz, Praveen Ramakrishnan Geethakumari, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat

Blood (2022) 140 (Supplement 1): 4749–4750.

https://doi.org/10.1182/blood-2022-166756

Published: 2022

Journal Articles

Racial and Ethnic Disparities in Acute Myeloid Leukemia: 15-Year Experience at a Safety-Net Health System

Sharlene Dong, Naveen Premnath, Navid Sadeghi, Radhika Kainthla, Stephen S. Chung, Madhuri Vusirikala, Robert H. Collins, Hsiao C. Li, Yazan F. Madanat

Blood (2022) 140 (Supplement 1): 3194–3195.

https://doi.org/10.1182/blood-2022-165285

Published: 2022

Journal Articles

Drug Combinations on AML Cell Lines' Treatment

Fatma Neslihan Kalkan, Ezgi Temamogullari Wood, Micheal Farid, Muhammed Sadik Yildiz, Stephen S. Chung, Erdal Toprak

Blood (2022) 140 (Supplement 1): 12999–13000.

https://doi.org/10.1182/blood-2022-171100

Published: 2022

Journal Articles

Leukemia Stem Cells Depend on Regulated Protein Synthesis

Yi Huang, Eda Gozel Kapti, Toby Thomas, Yuanyuan Ji, Dheepthi P. Ramasamy, Cedric B. Robinson, Stephen S Chung

Blood (2021) 138 (Supplement 1): 2222.

https://doi.org/10.1182/blood-2021-154519

Published: 2021

Journal Articles

Selinexor, a First-in-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents

Justin Taylor, MD, Morgan Coleman, MPH, Kelsey Alvarez, RN, Janine Pichardo, Filiz Sen, MD, Stephen S. Chung, MD, Raajit K. Rampal, MD PhD, Jae H. Park, MD, Eytan M. Stein, MD, Martin S. Tallman, MD, Omar I Abdel-Wahab, MD, Virginia M. Klimek, MD

Blood (2018) 132 (Supplement 1): 233.

https://doi.org/10.1182/blood-2018-99-113840

Published: 2018

Journal Articles

Genomic Analysis of Hairy Cell Leukemia Identifies Novel Recurrent Genetic Alterations

Blood (2017) 130 (Supplement 1): 2994.

https://doi.org/10.1182/blood.V130.Suppl_1.2994.2994

Published: 2017

NARROW

Compound Heterozygosity Involving Other Dead ( DDX ) and Deah ( DHX ) Box Helicases Explains Seemingly Monoallelic Somatic and Germline DDX41 Mutations

Incidence of Invasive Fungal Infections in CAR T-Cell Therapy Recipients: A Single-Center Retrospective Analysis

Utilization and Barriers to Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma: A ‘Real-World’ Study of Treatment Patterns and Outcomes at a Safety-Net Versus a Tertiary Academic Hospital

Somatic and Germline HLA Determinants of Immune Surveillance and Escape in Myelodysplastic Syndromes

Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm

Impact of First-Line Consolidative Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Mantle Cell Lymphoma (MCL): A 'Real-World' Study of Treatment Patterns and Outcomes at a Safety-Net Versus a Tertiary Academic Hospital

Defining Clonal Hematopoiesis in Childhood Cancer Survivors[a Prospective, Single Center Study]

Clonal Hematopoiesis and Heart Failure with Preserved Ejection Fraction

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

Treatment Patterns and Outcomes of Peripheral T-Cell Lymphoma (PTCL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution: Does Consolidative Autologous Stem Cell Transplantation (ASCT) Make a Difference?

Multi-Omic Approaches Reveal Leukemia Stem Cell Gene Regulatory Mechanisms

Impact of Bridging Therapy on Infectious Complications Post CAR T-Cell Therapy: The UT Southwestern Experience

Evaluating Stem Cells to Predict Post-Transplant Relapse in the Myelodysplastic Syndromes

Prevalence of Clonal Hematopoiesis in Patients with Monoclonal Gammopathy of Undetermined Significance

Post-Transplant Cyclophosphamide Associated with Increased Early Mixed Donor Chimerism in Myeloid Malignancies; A Single-Center Experience

Racial and Ethnic Disparities in Acute Myeloid Leukemia: 15-Year Experience at a Safety-Net Health System

Drug Combinations on AML Cell Lines' Treatment

Leukemia Stem Cells Depend on Regulated Protein Synthesis

Selinexor, a First-in-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents

Genomic Analysis of Hairy Cell Leukemia Identifies Novel Recurrent Genetic Alterations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only